down arrow

Sun Pharma.Inds.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,692.15
40.15 (2.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 24.03 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,682.651,735.80

52 Week

1,376.751,960.20
Valuation
Technical
Day's Volume

CASH

24.03 lacs (-16.11%) Volume

Shareholding (Dec 2024)

FII

18.05%

Held by 1165 FIIs

DII

18.55%

Held by 127 DIIs

Promoter

54.48%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Bearish range

  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 1.13% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2

With ROE of 16.2, it has a Expensive valuation with a 5.7 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 406,003 Cr (Large Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.94%

stock-summary
Debt Equity

-0.25

stock-summary
Return on Equity

16.22%

stock-summary
Price to Book

5.73

Revenue and Profits (1 Year):
Net Sales:
13,675 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2,903 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.94%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-11.03%
0.55%
-10.48%
1 Year
5.5%
1.02%
6.52%
2 Years
67.71%
2.91%
70.62%
3 Years
83.09%
4.53%
87.62%
4 Years
165.66%
6.91%
172.57%
5 Years
271.74%
11.51%
283.25%

Latest dividend: 10.5 per share ex-dividend date: Feb-06-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.32%
EBIT Growth (5y)
20.62%
EBIT to Interest (avg)
52.63
Debt to EBITDA (avg)
0.42
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.70
Tax Ratio
13.72%
Dividend Payout Ratio
33.82%
Pledged Shares
0.69%
Institutional Holding
36.60%
ROCE (avg)
18.52%
ROE (avg)
14.60%
Valuation key factors
Factor
Value
P/E Ratio
34
Industry P/E
33
Price to Book Value
5.73
EV to EBIT
31.49
EV to EBITDA
25.96
EV to Capital Employed
7.35
EV to Sales
7.34
PEG Ratio
1.31
Dividend Yield
0.94%
ROCE (Latest)
22.31%
ROE (Latest)
16.22%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

0.6862

Mutual Funds

Held by 43 Schemes (12.24%)

FIIs

Held by 1165 FIIs (18.05%)

Promoter with highest holding

Shanghvi Finance Private Limited (40.3%)

Highest Public shareholder

Icici Prudential Value Discovery Fund (3.26%)

Individual Investors Holdings

5.47%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 2.89% vs 5.05% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -4.50% vs 7.21% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13,675.46",
          "val2": "13,291.39",
          "chgp": "2.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,009.02",
          "val2": "3,938.96",
          "chgp": "1.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "51.51",
          "val2": "69.17",
          "chgp": "-25.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-316.17",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,903.38",
          "val2": "3,040.16",
          "chgp": "-4.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.84%",
          "val2": "29.70%",
          "chgp": "0.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25,944.14",
          "val2": "24,133.25",
          "chgp": "7.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,546.58",
          "val2": "6,511.15",
          "chgp": "15.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "130.71",
          "val2": "130.17",
          "chgp": "0.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-322.87",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,875.78",
          "val2": "4,398.05",
          "chgp": "33.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.26%",
          "val2": "27.37%",
          "chgp": "1.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.51% vs 10.80% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 26.83% vs 6.67% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39,619.60",
          "val2": "36,513.95",
          "chgp": "8.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11,555.60",
          "val2": "9,987.98",
          "chgp": "15.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "182.22",
          "val2": "164.90",
          "chgp": "10.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-316.17",
          "val2": "-392.68",
          "chgp": "19.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,779.16",
          "val2": "6,921.80",
          "chgp": "26.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.17%",
          "val2": "27.35%",
          "chgp": "1.82%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 10.51% vs 13.53% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 13.01% vs 158.91% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "48,496.85",
          "val2": "43,885.68",
          "chgp": "10.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13,023.13",
          "val2": "11,646.79",
          "chgp": "11.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "238.47",
          "val2": "172.00",
          "chgp": "38.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-494.32",
          "val2": "-171.45",
          "chgp": "-188.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9,576.38",
          "val2": "8,473.58",
          "chgp": "13.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.27%",
          "val2": "26.91%",
          "chgp": "0.36%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
13,675.46
13,291.39
2.89%
Operating Profit (PBDIT) excl Other Income
4,009.02
3,938.96
1.78%
Interest
51.51
69.17
-25.53%
Exceptional Items
-316.17
0.00
Consolidate Net Profit
2,903.38
3,040.16
-4.50%
Operating Profit Margin (Excl OI)
29.84%
29.70%
0.14%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 2.89% vs 5.05% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -4.50% vs 7.21% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
25,944.14
24,133.25
7.50%
Operating Profit (PBDIT) excl Other Income
7,546.58
6,511.15
15.90%
Interest
130.71
130.17
0.41%
Exceptional Items
0.00
-322.87
100.00%
Consolidate Net Profit
5,875.78
4,398.05
33.60%
Operating Profit Margin (Excl OI)
29.26%
27.37%
1.89%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
39,619.60
36,513.95
8.51%
Operating Profit (PBDIT) excl Other Income
11,555.60
9,987.98
15.70%
Interest
182.22
164.90
10.50%
Exceptional Items
-316.17
-392.68
19.48%
Consolidate Net Profit
8,779.16
6,921.80
26.83%
Operating Profit Margin (Excl OI)
29.17%
27.35%
1.82%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 8.51% vs 10.80% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 26.83% vs 6.67% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
48,496.85
43,885.68
10.51%
Operating Profit (PBDIT) excl Other Income
13,023.13
11,646.79
11.82%
Interest
238.47
172.00
38.65%
Exceptional Items
-494.32
-171.45
-188.32%
Consolidate Net Profit
9,576.38
8,473.58
13.01%
Operating Profit Margin (Excl OI)
27.27%
26.91%
0.36%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 10.51% vs 13.53% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 13.01% vs 158.91% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Sun Pharmaceutical Industries Ltd stock-summary
stock-summary
Sun Pharmaceutical Industries Ltd
Large Cap
Pharmaceuticals & Drugs
Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
Company Coordinates stock-summary
Company Details
Sun Pharma Advanced Res.Centre, Tandalja Vadodara Gujarat : 390020
stock-summary
Tel: 91-265-6615500
stock-summary
http://www.sunpharma.com
stock-summary
secretarial@sunpharma.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."